All Type of News
Will CSOs become the blue ocean in the pharmaceutical distribution industry?
The industry has paid attention whether CSOs(Contract Sales Organizations) will take the key role in creating a new market and changing the characteristics of the industry in the pharmaceutical distribution industry.
...
Daewoong Pharmaceutical about to launch first domestic generic in the U.S.‘Daewoong Meropenem Inj’ will first enter the U.S. as a Korean generic product.
On the 5th, Daewoong Pharmaceutical(CEO Jong-ok Lee) announced ‘Daewoong Meropenem Inj,’ a carba...
|
Chong Kun Dang targets Japanese market with domestically-first Nesp biosimilarChong Kun Dang(CEO Young-joo Kim) will target the Japanese market with ‘CKD-11101,’ a biosimilar of Nesp, the 2nd generation anemia treatment, which has been being developed for...
|
MSIP practically withdraws ‘online sales of household drugs’
It was rumored the Ministry of Science, ICT and Future Planning(MSIP) is working on the online commercialization of household drugs, but the ministry was confirmed to withdraw the plan already.
In the recently publis...
“Yearly 4-injection schizophrenia treatment is expected to be approved this year”
Schizophrenia is expected to be managed by injection 4 times a year.
Janssen Korea is currently taking the approval procedure of ‘Invega Sustenna(paliperidone, monthly injection), the only domestic long-acting inject...
Which is the company with the most patent-registered pharmaceutical products?
A pharmaceutical company which listed the most number of registered pharmaceutical products after the Patent Linkage System was researched to be MSD Korea last year.
According to the analysis result of patent-registe...
Hanmi President Sung-gi Lim donates stocks of KRW 110 billion to employeesPresident Sung-gi Lim, the founder of Hanmi Pharm, which wrote history in the domestic pharmaceutical industry as establishing 7 license agreements of KRW 8 trillion last year, ...
|
Chong Kun Dang makes joint sales of diabetes and hyperlipidemia treatments with MSD KoreaOn the 4th, Chong Kun Dang(CEO Young-joo Kim) announced it made the joint sales agreement of 3 diabetes treatments and 2 hyperlipidemia treatments with MSD Korea.
Under the ter...
|
Dong-A ST cut price of Zydena by 67% at the maximumDong-A ST(Soo-hyung Kang) lowered the price of ‘Zydena’ by 67%, at the maximum, on the 1st of January this year.
According to the company, the price reduction was decided to st...
|
Prohibited to distribute and sell cosmetics and ingredients experimented on animals
An act was decided to prohibit distribution and sales of cosmetic products experimented on animals. It was the first enactment of animal testing prohibition on cosmetics in South East Asia.
The National Assembly pass...
